The State Public Health Laboratory System
Teresa Miller, Chemical Threat Response Training
Coordinator, MDHHS Bureau of Laboratories
The State Public Health Laboratory System is defined as “An
alliance of laboratories and other partners within a state that supports the
ten essential public health services under the aegis of the state public health
laboratory. The system members and stakeholders operate in an interconnected
interdependent way to facilitate the exchange of information, optimize
laboratory services, and help control and prevent disease and public health
threats.”
The State Public Health Laboratory System>>
Interim 2017/18 Influenza Seasonal Vaccine Effectiveness: Combined Results From Five European Studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, −42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
A Framework for Healthcare Disaster Resilience: A View of the Future
This report is the culmination of a 2-year project funded by the Robert Wood Johnson Foundation to examine US disaster healthcare with the purpose of identifying changes, innovations, and new efforts that could strengthen the country’s ability to provide medical care in major disasters. In the report, there is an analysis of a range of disasters that could confront the United States and consider their impacts on the healthcare system, including how medical care would be delivered in those scenarios, both to victims of the disaster and everyone else.
A Framework for Healthcare Disaster Resilience: A View of the Future>>
|
